ConductScience.org, home

Comparison · NCT03463512-06d90cdb

Racecadotril Plus Standard Treatment Oral Rehydration Solution vs ORS (Standard Treatment): Number of Recovered Subjects as Defined by Global Physician Assessment of Success at the End of Treatment

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Racecadotril Plus Standard Treatment Oral Rehydration Solution vs ORS (Standard Treatment): Number of Recovered Subjects as Defined by Global Physician Assessment of Success at the End of Treatment. Trial comparisons, record NCT03463512-06d90cdb. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03463512-06d90cdb

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 110.9421wilson
Risk in group 20.9680.890.991wilson
Risk difference, group 1 minus group 20.0323-0.03060.11newcombe hybrid score
Risk ratio, group 1 over group 21.030.9871.08log
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to treat, for one more participant with the outcome on Racecadotril Plus Standard Treatment Oral Rehydration Solution than on ORS (Standard Treatment)31from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Racecadotril Plus Standard Treatment Oral Rehydration SolutionRacecadotril plus ORS: Racecadotril plus ORS6262OG000
Group 2ORS (Standard Treatment)ORS: ORS6062OG001

Outcome

Type
SECONDARY
Title
Number of Recovered Subjects as Defined by Global Physician Assessment of Success at the End of Treatment
Description
Globabl physician assessment used 6 scores with a score of 1 or 2 being regarded as treatment success
Time frame
5 days
Population
full analysis sample

Source ClinicalTrials.gov

Trial

Title
Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea
NCT number
NCT03463512
Phases
PHASE3
Conditions
Diarrhea
Interventions
Racecadotril plus ORS, ORS
Lead sponsor
Abbott
Results first posted
2019-10-23

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03463512-06d90cdb